Pure Global

Acquired genetic alteration IVDs - ARTG 270292

Access comprehensive regulatory information for Acquired genetic alteration IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 270292 and sponsored by Key Diagnostics Pty Ltd, manufactured by ViennaLab Diagnostics GmbH in Austria. The device registration started on February 16, 2016.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIb
ARTG 270292
Class IIb
Acquired genetic alteration IVDs
ARTG ID: 270292
Good Name: Key Diagnostics Pty Ltd - Acquired genetic alteration IVDs
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

IVDs that are intended to be used in genetic testing to provide information about acquired genetic alterations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information.The technology utilises PCR and reverse hybridisation.

Device Classification
Risk Class
Class IIb
Product Type
IVD
ARTG Category
IVD
Registration Information
ARTG ID
270292
Start Date
February 16, 2016
Effective Date
February 16, 2016
Manufacturer
Country
Austria
Address
43-45 Gaudenzdorfer Guertel, Vienna, A-1120